Brightstone Venture Capital
Brightstone Venture Capital manages a $100 million venture fund focused on early-growth stage investments. The firm invests primarily in Technology and Life Sciences sectors and leverages the operating experience and investment background of its partners to support portfolio companies.
Industries
Nr. of Employees
small (1-50)
Brightstone Venture Capital
510 First Ave N, Suite #200, Minneapolis, MN 55403
Portfolio
Provides iPS-based micro-organ platforms for drug toxicity and efficacy testing; IPO on NASDAQ (VYNT).
#Stem cell technologies / drug testing platforms
Described as a cloud storage platform; recently raised $112M in a Series C funding.
#Cloud storage / infrastructure
Delivers SSD controllers with host-based FTL and Ethernet I/O; recently raised $10M in a Series G funding.
#Semiconductor / SSD controller IP
Provides iPS-based micro-organ platforms for drug toxicity and efficacy testing; IPO on NASDAQ (VYNT).
#Stem cell technologies / drug testing platforms
Described as a cloud storage platform; recently raised $112M in a Series C funding.
#Cloud storage / infrastructure
Delivers SSD controllers with host-based FTL and Ethernet I/O; recently raised $10M in a Series G funding.
#Semiconductor / SSD controller IP